North America Gynecological Devices Market Outlook to 2023
May 2017
163
About the Report
About the Report
North America Gynecological Devices Market Outlook to 2023
Summary
GlobalData's new report, "North America Gynecological Devices Market Outlook to 2023", provides key market data on the North America Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments-Female Sterilization Devices, Endometrial Ablation Devices, Uterine Fibroid Ablation Devices and Uterine Fibroid Embolization Agents.
The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope
Market size and company share data for Gynecological Devices market segments-Female Sterilization Devices, Endometrial Ablation Devices, Uterine Fibroid Ablation Devices and Uterine Fibroid Embolization Agents.
Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
2016 company shares and distribution shares data for each of the market segments.
Global corporate-level profiles of key companies operating within the North America Gynecological Devices market.
Key players covered include Hologic Inc, CooperSurgical Inc, Ethicon Inc and Others.
Reasons to buy
Develop business strategies by identifying the key market segments poised for strong growth in the future.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.
Products
Companies
Bayer AG Hologic Inc Utah Medical Products, Inc. CooperSurgical Inc Ethicon Inc Boston Scientific Corp Merit Medical Systems, Inc. Cook Group Inc
Table of Contents
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 9
2.1 What Is This Report About? 9
2.2 Gynecological Devices Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 10
3 Gynecological Devices Market, North America 12
3.1 Gynecological Devices Market, North America, Revenue ($m), 2009-2023 12
3.2 Gynecological Devices Market, North America, Revenue ($m), 2009-2016 14
3.3 Gynecological Devices Market, North America, Revenue ($m), 2016-2023 16
3.4 Gynecological Devices Market, North America, Volume (Units), 2009-2023 18
3.5 Gynecological Devices Market, North America, Volume (Units), 2009-2016 20
3.6 Gynecological Devices Market, North America, Volume (Units), 2016-2023 22
3.7 Gynecological Devices Market, North America, Company Share by Revenue ($m), 2016 24
4 Gynecological Devices Market, Canada 26
4.1 Gynecological Devices Market, Canada, Revenue ($m), by Segment, 2009-2016 26
4.2 Gynecological Devices Market, Canada, Revenue ($m) by Segment, 2016-2023 28
4.2.1 Endometrial Ablation Devices Market, Canada, Revenue ($m), by Segment, 2009-2016 30
4.2.2 Female Sterilization Devices Market, Canada, Revenue ($m), by Segment, 2009-2016 32
4.2.3 Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m), by Segment, 2009-2016 34
4.2.4 Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m), by Segment, 2009-2016 35
4.2.5 Endometrial Ablation Devices Market, Canada, Revenue ($m) by Segment, 2016-2023 37
4.2.6 Female Sterilization Devices Market, Canada, Revenue ($m) by Segment, 2016-2023 39
4.2.7 Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m) by Segment, 2016-2023 41
4.2.8 Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m) by Segment, 2016-2023 42
4.3 Gynecological Devices Market, Canada, Volume (Units) by Segment, 2009-2016 44
4.4 Gynecological Devices Market, Canada, Volume (Units) by Segment, 2016-2023 46
4.4.1 Endometrial Ablation Devices Market, Canada, Volume (Units) by Segment, 2009-2016 48
4.4.2 Female Sterilization Devices Market, Canada, Volume (Units) by Segment, 2009-2016 50
4.4.3 Uterine Fibroid Ablation Devices Market, Canada, Volume (Units) by Segment, 2009-2016 52
4.4.4 Uterine Fibroid Embolization Agents Market, Canada, Volume (Units) by Segment, 2009-2016 53
4.4.5 Endometrial Ablation Devices Market, Canada, Volume (Units) by Segment, 2016-2023 55
4.4.6 Female Sterilization Devices Market, Canada, Volume (Units) by Segment, 2016-2023 57
4.4.7 Uterine Fibroid Ablation Devices Market, Canada, Volume (Units) by Segment, 2016-2023 59
4.4.8 Uterine Fibroid Embolization Agents Market, Canada, Volume (Units) by Segment, 2016-2023 60
4.5 Gynecological Devices Market, Canada, Average Price ($), 2009-2023 62
4.6 Gynecological Devices Market, Canada, Distribution Share by Revenue ($m), 2016 64
4.7 Gynecological Devices Market, Canada, Company Share by Revenue ($m), 2016 65
5 Gynecological Devices Market, Mexico 67
5.1 Gynecological Devices Market, Mexico, Revenue ($m), 2009-2016 67
5.2 Gynecological Devices Market, Mexico, Revenue ($m), 2016-2023 69
5.2.1 Endometrial Ablation Devices Market, Mexico, Revenue ($m), by Segment, 2009-2016 71
5.2.2 Female Sterilization Devices Market, Mexico, Revenue ($m), by Segment, 2009-2016 73
5.2.3 Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), by Segment, 2009-2016 75
5.2.4 Endometrial Ablation Devices Market, Mexico, Revenue ($m), by Segment, 2016-2023 77
5.2.5 Female Sterilization Devices Market, Mexico, Revenue ($m), by Segment, 2016-2023 79
5.2.6 Uterine Fibroid Ablation Devices Market, Mexico, Revenue ($m), by Segment, 2016-2023 81
5.2.7 Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), by Segment, 2016-2023 82
5.3 Gynecological Devices Market, Mexico, Volume (Units), 2009-2016 84
5.4 Gynecological Devices Market, Mexico, Volume (Units), 2016-2023 86
5.4.1 Endometrial Ablation Devices Market, Mexico, Volume (Units), by Segment, 2009-2016 88
5.4.2 Female Sterilization Devices Market, Mexico, Volume (Units), by Segment, 2009-2016 90
5.4.3 Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), by Segment, 2009-2016 92
5.4.4 Endometrial Ablation Devices Market, Mexico, Volume (Units), by Segment, 2016-2023 94
5.4.5 Female Sterilization Devices Market, Mexico, Volume (Units), by Segment, 2016-2023 96
5.4.6 Uterine Fibroid Ablation Devices Market, Mexico, Volume (Units), by Segment, 2016-2023 98
5.4.7 Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), by Segment, 2016-2023 99
5.5 Gynecological Devices Market, Mexico, Average Price ($), 2009-2023 101
5.6 Gynecological Devices Market, Mexico, Distribution Share by Revenue ($m), 2016 103
5.7 Gynecological Devices Market, Mexico, Company Share by Revenue ($m), 2016 104
6 Gynecological Devices Market, United States 106
6.1 Gynecological Devices Market, United States, Revenue ($m), 2009-2016 106
6.2 Gynecological Devices Market, United States, Revenue ($m), 2016-2023 108
6.2.1 Endometrial Ablation Devices Market, United States, Revenue ($m), by Segment, 2009-2016 110
6.2.2 Female Sterilization Devices Market, United States, Revenue ($m), by Segment, 2009-2016 112
6.2.3 Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), by Segment, 2009-2016 114
6.2.4 Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), by Segment, 2009-2016 115
6.2.5 Endometrial Ablation Devices Market, United States, Revenue ($m), by Segment, 2016-2023 117
6.2.6 Female Sterilization Devices Market, United States, Revenue ($m), by Segment, 2016-2023 119
6.2.7 Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), by Segment, 2016-2023 121
6.2.8 Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), by Segment, 2016-2023 122
6.3 Gynecological Devices Market, United States, Volume (Units), 2009-2016 124
6.4 Gynecological Devices Market, United States, Volume (Units), 2016-2023 126
6.4.1 Endometrial Ablation Devices Market, United States, Volume (Units), by Segment, 2009-2016 128
6.4.2 Female Sterilization Devices Market, United States, Volume (Units), by Segment, 2009-2016 130
6.4.3 Uterine Fibroid Ablation Devices Market, United States, Volume (Units), by Segment, 2009-2016 132
6.4.4 Uterine Fibroid Embolization Agents Market, United States, Volume (Units), by Segment, 2009-2016 133
6.4.5 Endometrial Ablation Devices Market, United States, Volume (Units), by Segment, 2016-2023 135
6.4.6 Female Sterilization Devices Market, United States, Volume (Units), by Segment, 2016-2023 137
6.4.7 Uterine Fibroid Ablation Devices Market, United States, Volume (Units), by Segment, 2016-2023 139
6.4.8 Uterine Fibroid Embolization Agents Market, United States, Volume (Units), by Segment, 2016-2023 140
6.5 Gynecological Devices Market, United States, Average Price ($), 2009-2023 142
6.6 Gynecological Devices Market, United States, Distribution Share by Revenue ($m), 2016 144
6.7 Gynecological Devices Market, United States, Company Share by Revenue ($m), 2016 145
7 Overview of Key Companies in North America Gynecological Devices Market 147
7.1 Bayer AG 147
7.1.1 Company Overview 147
7.2 Hologic Inc 147
7.2.1 Company Overview 147
7.3 Utah Medical Products, Inc. 147
7.3.1 Company Overview 147
7.4 CooperSurgical Inc 148
7.4.1 Company Overview 148
7.5 Ethicon Inc 148
7.5.1 Company Overview 148
7.6 Boston Scientific Corp 148
7.6.1 Company Overview 148
7.7 Merit Medical Systems, Inc. 149
7.7.1 Company Overview 149
7.8 Cook Group Inc 149
7.8.1 Company Overview 149
8 Gynecological Devices Market Pipeline Products 150
9 Recent Developments 151
9.1 Corporate Communications 151
9.1.1 Nov 15, 2016: Cynosure Health Welcomes Three New Board Members 151
9.1.2 Nov 01, 2016: Cynosure Promotes Doug Delaney to Chief Commercial Officer 151
9.1.3 Sep 13, 2016: Cynosure to Name Stephen J. Webber as New Chief Financial Officer 152
9.1.4 May 25, 2016: Cynosure Announces Planned Retirement of Timothy W. Baker as President, Chief Financial Officer and Chief Operating Officer 152
9.2 Financial Announcements 153
9.2.1 Feb 07, 2017: Cynosure Achieves Record Quarterly Revenue of $122.1 Million in the Fourth Quarter of 2016, Up 19 Percent Year-over-Year 153
9.2.2 Oct 25, 2016: Cynosure Announces Record Third-Quarter Revenues; Revenues Increase 36 Percent from Prior Year to $106.4 Million 154
9.2.3 Jul 26, 2016: Cynosure Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter of 2016 155
10 Appendix 157
10.1 Research Methodology 158
10.1.1 Coverage 158
10.1.2 Secondary Research 158
10.1.3 Primary Research 159
10.1.4 Market Modeling and Forecasting 160
10.1.5 Company Share Analysis 161
10.1.6 Distribution Share Analysis 162
10.1.7 Benchmarking 162
10.2 GlobalData Consulting 162
10.3 Contact Us 163
10.4 Disclaimer 163
List of Figure
1.2 List of Figures
Figure 1: Gynecological Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2009-2023 12
Figure 2: Gynecological Devices Market, North America, Revenue ($m), Historic, USD Constant, 2009-2016 14
Figure 3: Gynecological Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2016-2023 16
Figure 4: Gynecological Devices Market, North America, Volume (Units), 2009-2023 18
Figure 5: Gynecological Devices Market, North America, Volume (Units), Historic, 2009-2016 20
Figure 6: Gynecological Devices Market, North America, Volume (Units), Forecast, 2016-2023 22
Figure 7: Gynecological Devices Market, North America, Company Share (%) 2016 24
Figure 8: Gynecological Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 26
Figure 9: Gynecological Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 28
Figure 10: Endometrial Ablation Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 30
Figure 11: Female Sterilization Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 32
Figure 12: Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 34
Figure 13: Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 35
Figure 14: Endometrial Ablation Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 37
Figure 15: Female Sterilization Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 39
Figure 16: Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 41
Figure 17: Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 42
Figure 18: Gynecological Devices Market, Canada, Volume (Units), Historic, 2009-2016 44
Figure 19: Gynecological Devices Market, Canada, Volume (Units), Forecast, 2016-2023 46
Figure 20: Endometrial Ablation Devices Market, Canada, Volume (Units), Historic, 2009-2016 48
Figure 21: Female Sterilization Devices Market, Canada, Volume (Units), Historic, 2009-2016 50
Figure 22: Uterine Fibroid Ablation Devices Market, Canada, Volume (Units), Historic, 2009-2016 52
Figure 23: Uterine Fibroid Embolization Agents Market, Canada, Volume (Units), Historic, 2009-2016 53
Figure 24: Endometrial Ablation Devices Market, Canada, Volume (Units), Forecast, 2016-2023 55
Figure 25: Female Sterilization Devices Market, Canada, Volume (Units), Forecast, 2016-2023 57
Figure 26: Uterine Fibroid Ablation Devices Market, Canada, Volume (Units), Forecast, 2016-2023 59
Figure 27: Uterine Fibroid Embolization Agents Market, Canada, Volume (Units), Forecast, 2016-2023 60
Figure 28: Gynecological Devices Market, Canada, Company Share (%) 2016 65
Figure 29: Gynecological Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 67
Figure 30: Gynecological Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 69
Figure 31: Endometrial Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 71
Figure 32: Female Sterilization Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 73
Figure 33: Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 75
Figure 34: Endometrial Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 77
Figure 35: Female Sterilization Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 79
Figure 36: Uterine Fibroid Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 81
Figure 37: Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 82
Figure 38: Gynecological Devices Market, Mexico, Volume (Units), Historic, 2009-2016 84
Figure 39: Gynecological Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 86
Figure 40: Endometrial Ablation Devices Market, Mexico, Volume (Units), Historic, 2009-2016 88
Figure 41: Female Sterilization Devices Market, Mexico, Volume (Units), Historic, 2009-2016 90
Figure 42: Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), Historic, 2009-2016 92
Figure 43: Endometrial Ablation Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 94
Figure 44: Female Sterilization Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 96
Figure 45: Uterine Fibroid Ablation Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 98
Figure 46: Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), Forecast, 2016-2023 99
Figure 47: Gynecological Devices Market, Mexico, Company Share (%) 2016 104
Figure 48: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 106
Figure 49: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 108
Figure 50: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 110
Figure 51: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 112
Figure 52: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 114
Figure 53: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 115
Figure 54: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 117
Figure 55: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 119
Figure 56: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 121
Figure 57: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 122
Figure 58: Gynecological Devices Market, United States, Volume (Units), Historic, 2009-2016 124
Figure 59: Gynecological Devices Market, United States, Volume (Units), Forecast, 2016-2023 126
Figure 60: Endometrial Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016 128
Figure 61: Female Sterilization Devices Market, United States, Volume (Units), Historic, 2009-2016 130
Figure 62: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016 132
Figure 63: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Historic, 2009-2016 133
Figure 64: Endometrial Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023 135
Figure 65: Female Sterilization Devices Market, United States, Volume (Units), Forecast, 2016-2023 137
Figure 66: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023 139
Figure 67: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Forecast, 2016-2023 140
Figure 68: Gynecological Devices Market, United States, Company Share (%) 2016 145
List of Table
1.1 List of Tables
Table 1: Gynecological Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2009-2023 13
Table 2: Gynecological Devices Market, North America, Revenue ($m), Historic, USD Constant, 2009-2016 15
Table 3: Gynecological Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2016-2023 17
Table 4: Gynecological Devices Market, North America, Volume (Units), 2009-2023 19
Table 5: Gynecological Devices Market, North America, Volume (Units), Historic, 2009-2016 21
Table 6: Gynecological Devices Market, North America, Volume (Units), Forecast, 2016-2023 23
Table 7: Gynecological Devices Market, North America, Company Share by Revenue ($m), USD Constant, 2016 25
Table 8: Gynecological Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 27
Table 9: Gynecological Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 29
Table 10: Endometrial Ablation Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 31
Table 11: Female Sterilization Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 33
Table 12: Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 34
Table 13: Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 36
Table 14: Endometrial Ablation Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 38
Table 15: Female Sterilization Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 40
Table 16: Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 41
Table 17: Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023 43
Table 18: Gynecological Devices Market, Canada, Volume (Units) , Historic, 2009-2016 45
Table 19: Gynecological Devices Market, Canada, Volume (Units) , Forecast, 2016-2023 47
Table 20: Endometrial Ablation Devices Market, Canada, Volume (Units) , Historic, 2009-2016 49
Table 21: Female Sterilization Devices Market, Canada, Volume (Units) , Historic, 2009-2016 51
Table 22: Uterine Fibroid Ablation Devices Market, Canada, Volume (Units) , Historic, 2009-2016 52
Table 23: Uterine Fibroid Embolization Agents Market, Canada, Volume (Units) , Historic, 2009-2016 54
Table 24: Endometrial Ablation Devices Market, Canada, Volume (Units) , Forecast, 2016-2023 56
Table 25: Female Sterilization Devices Market, Canada, Volume (Units) , Forecast, 2016-2023 58
Table 26: Uterine Fibroid Ablation Devices Market, Canada, Volume (Units) , Forecast, 2016-2023 59
Table 27: Uterine Fibroid Embolization Agents Market, Canada, Volume (Units) , Forecast, 2016-2023 61
Table 28: Gynecological Devices Market, Canada, Average Price ($) Historic, 2009-2016 62
Table 29: Gynecological Devices Market, Canada, Average Price ($), Forecast, 2016-2023 63
Table 30: Gynecological Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2016 64
Table 31: Gynecological Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2016 66
Table 32: Gynecological Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 68
Table 33: Gynecological Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 70
Table 34: Endometrial Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 72
Table 35: Female Sterilization Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 74
Table 36: Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 76
Table 37: Endometrial Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 78
Table 38: Female Sterilization Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 80
Table 39: Uterine Fibroid Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 81
Table 40: Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 83
Table 41: Gynecological Devices Market, Mexico, Volume (Units), Historic, 2009-2016 85
Table 42: Gynecological Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 87
Table 43: Endometrial Ablation Devices Market, Mexico, Volume (Units), Historic, 2009-2016 89
Table 44: Female Sterilization Devices Market, Mexico, Volume (Units), Historic, 2009-2016 91
Table 45: Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), Historic, 2009-2016 93
Table 46: Endometrial Ablation Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 95
Table 47: Female Sterilization Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 97
Table 48: Uterine Fibroid Ablation Devices Market, Mexico, Volume (Units), Forecast, 2016-2023 98
Table 49: Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), Forecast, 2016-2023 100
Table 50: Gynecological Devices Market, Mexico, Average Price ($) Historic, 2009-2016 101
Table 51: Gynecological Devices Market, Mexico, Average Price ($), Forecast, 2016-2023 102
Table 52: Gynecological Devices Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2016 103
Table 53: Gynecological Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2016 105
Table 54: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 107
Table 55: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 109
Table 56: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 111
Table 57: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 113
Table 58: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 114
Table 59: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 116
Table 60: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 118
Table 61: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 120
Table 62: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 121
Table 63: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 123
Table 64: Gynecological Devices Market, United States, Volume (Units), Historic, 2009-2016 125
Table 65: Gynecological Devices Market, United States, Volume (Units), Forecast, 2016-2023 127
Table 66: Endometrial Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016 129
Table 67: Female Sterilization Devices Market, United States, Volume (Units), Historic, 2009-2016 131
Table 68: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016 132
Table 69: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Historic, 2009-2016 134
Table 70: Endometrial Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023 136
Table 71: Female Sterilization Devices Market, United States, Volume (Units), Forecast, 2016-2023 138
Table 72: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023 139
Table 73: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Forecast, 2016-2023 141
Table 74: Gynecological Devices Market, United States, Average Price ($) Historic, 2009-2016 142
Table 75: Gynecological Devices Market, United States, Average Price ($), Forecast, 2016-2023 143
Table 76: Gynecological Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2016 144
Table 77: Gynecological Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016 146
Table 78: Gynecological Devices Market Pipeline Products 150
Table 79: Total Number of Primary Research Participants General Surgery Market, by Country 160
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.